Insmed Incorporated INSM
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 239.97% | 185.76% | 115.09% | 66.73% | 30.34% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 239.97% | 185.76% | 115.09% | 66.73% | 30.34% |
| Cost of Revenue | 126.06% | 94.69% | 66.45% | 43.38% | 34.39% |
| Gross Profit | 274.88% | 214.97% | 130.04% | 73.94% | 29.15% |
| SG&A Expenses | 52.13% | 58.51% | 55.34% | 52.06% | 54.66% |
| Depreciation & Amortization | 109.29% | 51.17% | 34.98% | 18.78% | 5.44% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 49.78% | 47.10% | 43.93% | 39.20% | 37.29% |
| Operating Income | 36.07% | 12.40% | -12.36% | -26.47% | -40.68% |
| Income Before Tax | 49.28% | 15.61% | -16.74% | -39.74% | -36.97% |
| Income Tax Expenses | 59.27% | 39.91% | 38.44% | 35.58% | 37.86% |
| Earnings from Continuing Operations | 48.84% | 15.38% | -16.83% | -39.73% | -36.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 48.84% | 15.38% | -16.83% | -39.73% | -36.97% |
| EBIT | 36.07% | 12.40% | -12.36% | -26.47% | -40.68% |
| EBITDA | 37.57% | 13.35% | -11.67% | -26.07% | -40.82% |
| EPS Basic | 54.44% | 28.02% | 3.42% | -14.62% | -11.26% |
| Normalized Basic EPS | 41.94% | 25.33% | 6.79% | -3.43% | -12.24% |
| EPS Diluted | 54.43% | 27.99% | 3.38% | -14.66% | -11.30% |
| Normalized Diluted EPS | 41.94% | 25.33% | 6.79% | -3.43% | -12.24% |
| Average Basic Shares Outstanding | 13.71% | 18.72% | 20.61% | 21.29% | 22.40% |
| Average Diluted Shares Outstanding | 13.71% | 18.72% | 20.61% | 21.29% | 22.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |